Discontinuation: PenMix30 Penfill 3ml, NovoMix30 FlexPen 3ml, Actrapid Penfill 3ml and Protaphane Penfill 3ml.

Discontinuation:

We are writing to remind you that NovoNordisk are rationalising their product range and discontinuing four insulins. Please begin transitioning your patients to suitable alternatives.

Key Dates:

• PenMix30 Penfill 3ml

  
  

Supply of the PenMix30 ended October 2025. The remaining stock expires in April 2026. This will be delisted (no longer funded) 1 May 2026.

Please see advice: NZSSD Guidance: Discontinuation of Penmix30 and Penmix50 and Mixtard 30, July 2024. Note this advice mentions Novomix30. However, Novomix30 will be discontinued later in 2026.

• NovoMix 30 FlexPen 3 ml prefilled disposable pen

  
  

The supplier will stop selling this product by the end of 2026.

From 1 May 2025, we have funded Ryzodeg which may be a suitable alternative to NovoMix 30. 

• Actrapid Penfill 3ml

  
  

The supplier will stop selling this product by the end of 2026. 

• Protaphane Penfill 3ml 

  
  

The supplier will stop selling this product by the end of 2026. 

More information is available on our website:

Insulin discontinuations on Pharmac website This will continue to be updated.

Questions: 

If you have any queries, please contact us at enquiry@pharmac.govt.nz

Please share this information:

Please share this information with your colleagues and within your networks.

Ngā mihi,

Anna I Senior Advisor Implementation

Pharmac | Te Pātaka Whaioranga | PO Box 10 254 | Level 9, 40 Mercer Street, Wellington

P: 0800 660 050 | www.pharmac.govt.nz